QualityStocksNewsBreaks Archives - Page 317 of 1503

WednesdaySep 06, 2023 10:30 am

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Record Capacity Levels for Fr8Fleet

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform that offers a B2B cloud-based solution for cross-border and domestic shipping within the USMCA region. The company reported a record number of active carriers in its Fr8Fleet brand at end of August 2023, an increase of 60.8% versus year-ago levels and an increase of 55.7% versus YTD average capacity levels through August. “Following a challenging first quarter of the year, we had to cycle through some underperforming carriers during Q1-23 – which hurt our numbers for the first quarter, but we believe we…

WednesdaySep 06, 2023 10:17 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP), RippleLink Partner to Provide Private LTE, Enhanced Connectivity to ASR Customers

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is collaborating with RippleLink, a Private LTE systems integrator. The partnership will provide Private LTE design and deployment services designed to offer “blazing fast” connectivity with Knightscope’s ASR service when using traditional, public-use cellular service. According to the announcement, Private LTE, a wireless technology, features the reliability, performance, security and low latency needed to deliver the best possible experience for customers using the ASR platform. The partnership calls for RippleLink to supply all essential hardware, software, design, RF planning, implementation, RF validation and…

TuesdaySep 05, 2023 12:00 pm

QualityStocksNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present at Upcoming H.C. Wainwright Global Investment Conference

Longeveron (NASDAQ: LGVN, LGVNR), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty, today announced that its management will be participating in the 25th Annual H.C. Wainwright Global Investment Conference. The event is slated to take place in New York City from Sept. 11-13, 2023. Longeveron’s CEO Wa’el Hashad will give a pre-recorded presentation highlighting the company’s cellular therapy programs, which will be available on-demand by clicking here for the duration of the conference. The company’s CFO Lisa Locklear will also attend the…

TuesdaySep 05, 2023 11:46 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at Upcoming H.C. Wainwright Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at the 25th annual H.C. Wainwright Global Investment Conference. The conference is slated for Sept. 11–13, 2023, in New York City. According to the announcement, CNS Pharmaceuticals CEO Climaco is scheduled to present during the two-day conference; his live webcast presentation is scheduled for Wednesday, Sept. 13, at 10:30 a.m. ET. In addition to the presentation, key CNPS officials will be available to participate in in-person and virtual one-on-one meetings with…

TuesdaySep 05, 2023 11:03 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO to Present at Upcoming H.C. Wainwright Conference

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that it will present virtually at the H.C. Wainwright 25th Annual Global Investment Conference taking place on Monday, Sept. 11, 2023. The announcement reads, “Knightscope’s Chairman and CEO, William Santana Li, will deliver a corporate overview followed by question-and-answer sessions with analysts and attendees. The event begins at 7:00 a.m. ET and will be available on demand by registering here.” To view the full press release, visit https://ibn.fm/5Kx4V About Knightscope, Inc. Knightscope is an advanced public safety technology company that builds fully…

FridaySep 01, 2023 3:45 pm

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) Looking to Improve North America’s Graphite Infrastructure Efficiencies to Meet Surging Demand

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) is advancing its flagship Ruby Graphite Project in Beaverhead County in southwestern Montana. “With its ‘mine-to-market’ strategy, Reflex aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications… Preliminary results from the TDEM and magnetic survey have demonstrated promising anomalies, indicating the presence of conductive structures, several new anomalies, and potential graphite mineral deposits within the Ruby Graphite property. The survey data will be integrated with existing…

FridaySep 01, 2023 2:43 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs

BiondVax (NASDAQ: BVXV), a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently received coverage in analysis by Aegis Capital Corp. The report, which reiterated a buy recommendation and $70 target price for BVXV, contained analysis highlighting a deal valued at approximately $2.4 billion for Eli Lilly and Company’s (NYSE: LLY) acquisition of DICE Therapeutics Inc. (NASDAQ: DICE), a biopharmaceutical company that develops oral therapeutic candidates – such as DC-806 and DC-853, both oral interleukin-17 (“IL-17”) inhibitors – currently in…

FridaySep 01, 2023 1:09 pm

QualityStocksNewsBreaks – Why Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Is ‘One to Watch’

Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation, and development company focusing on conventional oil and gas reservoirs in Western Canada, uses its experience to develop, acquire and drill assets with potential for primary and secondary recovery. “Prospera’s core properties include more than 42,000 cumulative acres across Cuthbert, Luseland and Heart Hills in Saskatchewan and Red Earth and Pouce Coupe in Alberta. In total, the company estimates that there are half a billion barrels of oil in place at these sites accounting for 20+ years of forward project lifespan, with as little as 8%…

FridaySep 01, 2023 12:55 pm

QualityStocksNewsBreaks – GolfLync Inc.’s Pebble Beach Sweepstakes Provides Once-in-a-Lifetime Opportunity for Golf Enthusiasts

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, previously announced the launch of the GolfLync Pebble Beach Sweepstakes. “This exciting sweepstakes gives golf enthusiasts a chance to win a dream golf trip to the iconic Pebble Beach Resorts, renowned as the No. 1 Golf Resort in America… As the greatest public golf course in America, as rated by Golf Digest, Pebble Beach has a rich history of hosting prestigious tournaments, including the U.S. Open and, for the first time in 2023, the U.S. Women’s Open. This sweepstakes provides a once-in-a-lifetime opportunity…

FridaySep 01, 2023 12:09 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures Patent Protection in ‘Some of the Most Important Markets in the World’

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently received a patent from the China National Intellectual Property Administration. “The granted patent broadly covers the use of the company’s drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers. The REQORSA gene therapy in combination with Keytruda is the subject of the company’s ongoing Acclaim-2 clinical trial for the treatment of non-small cell lung cancer (‘NSCLC’). In this trial, the company is enrolling and treating patients with advanced, metastatic NSCLC whose disease progressed…

Site Search

Company Search

Category: QualityStocksNewsBreaks